Synthorx, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJan 23, 2020
- Entered a material agreement · Director / officer change · Other material eventDec 9, 2019
- Other material eventNov 8, 2019
- Other material eventNov 8, 2019
- Results of operationsNov 5, 2019
- Other material eventSep 30, 2019
- Other material eventSep 16, 2019
- Director / officer changeSep 13, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SEC STAFF LETTERFeb 18, 2020
- SC 13G/APRIMARY DOCUMENTFeb 14, 2020
- SEC STAFF LETTERFeb 10, 2020
- SC 13G/AFeb 7, 2020
- 15-12BFeb 3, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
- 4FORM 4 SUBMISSIONJan 24, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.